EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial)

Yin-Kai Chao iD, Zhigang Li, Hongjing Jiang, Yu-Wen Wen, Chen-Hung Chiu, Bin Li, Xiaobin Shang, Tuan-Jen Fang, Yang Yang iD, Jie Yue, Xiaobin Zhang, Chen Zhang und 1 weitere

British Journal of Surgery · 02.07.2024 · 111 (7)

DOI: 10.1093/bjs/znae143 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 04.07.2024. Verfasst von Yin-Kai Chao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Esophagectomy, Robotic Surgical Procedures, Thoracic Surgery, Video-Assisted, Esophageal Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chang Gung Memorial Hospital, Taiwan, Shanghai Academic/Technology Research Leader, China, Precision Treatment Technology for Oncology Surgery program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surgery for oesophageal squamous cell carcinoma involves dissecting lymph nodes along the recurrent laryngeal nerve. This is technically challenging and injury to the recurrent laryngeal nerve may lead to vocal cord palsy, which increases the risk of pulmonary complications. The aim of this study was to compare the efficacy and safety of robot-assisted oesophagectomy (RAO) versus video-assisted thoracoscopic oesophagectomy (VAO) for dissection of lymph nodes along the left RLN.

Methods

Patients with oesophageal squamous cell carcinoma who were scheduled for minimally invasive McKeown oesophagectomy were allocated randomly to RAO or VAO, stratified by centre. The primary endpoint was the success rate of left recurrent laryngeal nerve lymph node dissection. Success was defined as the removal of at least one lymph node without causing nerve damage lasting longer than 6 months. Secondary endpoints were perioperative and oncological outcomes.

Results

From June 2018 to March 2022, 212 patients from 3 centres in Asia were randomized, and 203 were included in the analysis (RAO group 103; VAO group 100). Successful left recurrent laryngeal nerve lymph node dissection was achieved in 88.3% of the RAO group and 69% of the VAO group (P < 0.001). The rate of removal of at least one lymph node according to pathology was 94.2% for the RAO and 86% for the VAO group (P = 0.051). At 1 week after surgery, the RAO group had a lower incidence of left recurrent laryngeal nerve palsy than the VAO group (20.4 versus 34%; P = 0.029); permanent recurrent laryngeal nerve palsy rates at 6 months were 5.8 and 20% respectively (P = 0.003). More mediastinal lymph nodes were dissected in the RAO group (median 16 (i.q.r. 12–22) versus 14 (10–20); P = 0.035). Postoperative complication rates were comparable between the two groups and there were no in-hospital deaths.

Conclusion

In patients with oesophageal squamous cell carcinoma, RAO leads to more successful left recurrent laryngeal nerve lymph node dissection than VAO, including a lower rate of short- and long-term recurrent laryngeal nerve injury. Registration number: NCT03713749 (http://www.clinicaltrials.gov).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EsophagectomyRobotic Surgical ProceduresThoracic Surgery, Video-AssistedEsophageal NeoplasmsLymph Node ExcisionHumansMaleFemaleMiddle AgedAgedEsophageal Squamous Cell CarcinomaPostoperative ComplicationsTreatment OutcomeRecurrent Laryngeal NerveRecurrent Laryngeal Nerve InjuriesAdult

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Division of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China.
  • Department of Minimally Invasive Oesophageal Surgery, Key Laboratory of Prevention and Therapy, National Clinical Research Centre of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Otorhinolaryngology Head and Neck Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.

ORCID-Profile: Yin-Kai Chao, Yang Yang

Förderung

  • Chang Gung Memorial Hospital, Taiwan
  • Shanghai Academic/Technology Research Leader, China
  • Precision Treatment Technology for Oncology Surgery program
  • me
  • Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
  • Intuitive Surgical

Zitieren

APA

Chao, Y. K., Li, Z., Jiang, H., Wen, Y. W., Chiu, C. H., Li, B., Shang, X., Fang, T. J., Yang, Y., Yue, J., Zhang, X., Zhang, C., & Liu, Y. H. (2024). Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial). British Journal of Surgery, 111(7). https://doi.org/10.1093/bjs/znae143

Vancouver

Chao YK, Li Z, Jiang H, Wen YW, Chiu CH, Li B, et al. Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial). British Journal of Surgery. 2024;111(7). doi:10.1093/bjs/znae143

BibTeX
@article{Chao2024,
  author = {Chao, Yin-Kai and Li, Zhigang and Jiang, Hongjing and Wen, Yu-Wen and Chiu, Chen-Hung and Li, Bin and Shang, Xiaobin and Fang, Tuan-Jen and Yang, Yang and Yue, Jie and Zhang, Xiaobin and Zhang, Chen and Liu, Yun-Hen},
  title = {Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial)},
  journal = {British Journal of Surgery},
  year = {2024},
  volume = {111},
  number = {7},
  doi = {10.1093/bjs/znae143}
}
Kostenlos starten →